Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Blog > 2020 > WE CARE ABOUT YOUR OPINION

WE CARE ABOUT YOUR OPINION

ChemDiv invites you to participate in our customer experience survey.

Our team works hard to provide the best service for you.

Dear ChemDiv customers,

ChemDiv invites you to participate in our customer experience survey. Our team works hard to provide the best service for you.

We put customer satisfaction as our priority. Please help us to make your experience better.

© 2020 ChemDiv Inc.

Read also

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

Science & Nature reviews, August 2021 (2)

Science & Nature reviews, August 2021 (2)

These are ChemDiv's reviews on Nature and Science Journal articles.

OCULAR DISEASES SMALL MOLECULES LIBRARY

OCULAR DISEASES SMALL MOLECULES LIBRARY

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept